Microparticle-based technologies for vaccines

被引：123

作者：

O'Hagan, Derek T. ^{[1
]}

Singh, Manmohan ^{[1
]}

Ulmer, Jeffrey B. ^{[1
]}

机构：

[1] Novartis Vaccines & Diagnost Inc, Vaccines Res, Emeryville, CA 94608 USA

来源：

METHODS | 2006年 / 40卷 / 01期

关键词：

adjuvants; delivery systems; innate immunity; toll-like receptors; antibodies; helper T lymphocytes; cytotoxic T lymphocytes;

D O I：

10.1016/j.ymeth.2006.05.017

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Microparticles have been effectively used for many years as delivery systems for drugs and therapeutic proteins. Their application to the delivery of vaccines is not as extensive, but is growing. Utility has been demonstrated for the delivery of various types of vaccines (e.g., recombinant proteins, plasmid DNA, and peptides) and other vaccine components (e.g., immune potentiators). With respect to delivery of immune potentiators, synergistic effects are often observed whereby much more potent immune responses are induced with a combination than with either component alone. Hence, the prospects for broad application of microparticle-based delivery systems for vaccines are excellent. (c) 2006 Elsevier Inc. All rights reserved.

引用

页码：10 / 19

页数：10

共 133 条

[11] Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients [J].

Calarota, S ;

Bratt, G ;

Nordlund, S ;

Hinkula, J ;

Leandersson, AC ;

Sandström, E ;

Wahren, B .

LANCET, 1998, 351 (9112) :1320-1325

[12] Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application [J].

Caputo, A ;

Brocca-Cofano, E ;

Castaldello, A ;

De Michele, R ;

Altavilla, G ;

Marchisio, M ;

Gavioli, R ;

Rolen, U ;

Chiarantini, L ;

Cerasi, A ;

Dominici, S ;

Magnani, M ;

Cafaro, A ;

Sparnacci, K ;

Laus, M ;

Tondelli, L ;

Ensoli, B .

VACCINE, 2004, 22 (21-22) :2910-2924

[13] Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles [J].

Challacombe, SJ ;

Rahman, D ;

OHagan, DT .

VACCINE, 1997, 15 (02) :169-175

[14] Development of a single-shot subunit vaccine for HIV-1 .3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120 [J].

Cleland, JL ;

Barron, L ;

Daugherty, A ;

Eastman, D ;

Kensil, C ;

Lim, A ;

Weissburg, RP ;

Wrin, T ;

Vennari, J ;

Powell, MF .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (12) :1350-1357

[15] Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles:: effect of formulation and route of immunization on induction of Th1 and Th2 cells [J].

Conway, MA ;

Madrigal-Estebas, L ;

McClean, S ;

Brayden, DJ ;

Mills, KHG .

VACCINE, 2001, 19 (15-16) :1940-1950

[16] Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells [J].

Denis-Mize, KS ;

Dupuis, M ;

MacKichan, ML ;

Singh, M ;

Doe, B ;

O'Hagan, D ;

Ulmer, JB ;

Donnelly, JJ ;

McDonald, DM ;

Ott, G .

GENE THERAPY, 2000, 7 (24) :2105-2112

[17] Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres [J].

Diwan, M ;

Tafaghodi, M ;

Samuel, J .

JOURNAL OF CONTROLLED RELEASE, 2002, 85 (1-3) :247-262

[18]

Egilmez NK, 2000, CANCER RES, V60, P3832

[19] BIODEGRADABLE AND BIOCOMPATIBLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES AS AN ADJUVANT FOR STAPHYLOCOCCAL ENTEROTOXIN-B TOXOID WHICH ENHANCES THE LEVEL OF TOXIN-NEUTRALIZING ANTIBODIES [J].

ELDRIDGE, JH ;

STAAS, JK ;

MEULBROEK, JA ;

TICE, TR ;

GILLEY, RM .

INFECTION AND IMMUNITY, 1991, 59 (09) :2978-2986

[20] CONTROLLED VACCINE RELEASE IN THE GUT-ASSOCIATED LYMPHOID-TISSUES .1. ORALLY-ADMINISTERED BIODEGRADABLE MICROSPHERES TARGET THE PEYERS PATCHES [J].

ELDRIDGE, JH ;

HAMMOND, CJ ;

MEULBROEK, JA ;

STAAS, JK ;

GILLEY, RM ;

TICE, TR .

JOURNAL OF CONTROLLED RELEASE, 1990, 11 (1-3) :205-214

← 1 2 3 4 5 6 7 8 9 10 →